Genolimzumab
Genolimzumab Uses, Dosage, Side Effects, Food Interaction and all others data.
Genolimzumab is under investigation in clinical trial NCT03502629 (Clinical Trial in Chinese Patients of Relapsed and Refractory Peripheral T Cell Lymphoma (GB226)).
Trade Name | Genolimzumab |
Generic | Geptanolimab |
Geptanolimab Other Names | Genolimzumab, Geptanolimab |
Type | |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Genolimzumab